Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Ophthalmology. 2016 Feb 16;123(6):1297–1308. doi: 10.1016/j.ophtha.2015.12.026

Table 1.

Selected Baseline Characteristics from Individuals who Participated in Exams 2 and 5 and did not have Late Age-Related Macular Degeneration at Baseline, Overall and by Racial/Ethnic Group, in the Multi-Ethnic Study of Atherosclerosis

Characteristic* All Participants (n=3802) [Mean (SD) or % (n)] Whites Participants (n=1549) [Mean (SD) or % (n)] Blacks Participants (n=949) [Mean (SD) or %] Hispanic Participants (n=841) [Mean (SD) or %] Chinese Participants (n=463) [Mean (SD) or % (n)] p-value**


Age (yrs) 60.8 (9.1) 61.1 (9.2) 60.6 (8.7) 60.3 (9.2) 60.5 (9.1) 0.001
Sex (% male) 46.9% (1783) 47.6% (737) 44.3% (420) 47.0% (395) 49.9% (231) 0.291
Race/Ethnicity
 White 40.7% (1549) -- -- -- -- --
 Black 25.0% (949) -- -- -- -- --
 Hispanic 22.1% (841) -- -- -- -- --
 Chinese 12.2% (463) -- -- -- -- --
Cigarette Smoking
 Past 41.1% (1552) 47.4% (729) 41.7% (392) 39.5% (330) 21.9% (101) < 0.001
 Current 11.1% (419) 10.2% (157) 15.7% (148) 10.8% (90) 5.2% (24) < 0.001
Diastolic Blood Pressure, Seated (mmHg) 70.6 (10.0) 69.0 (9.6) 73.7 (9.9) 70.5 (10.0) 69.9 (9.7) < 0.001
Body Mass Index (kg/m2) 28.4 (5.4) 27.9 (5.2) 30.2 (5.5) 29.5 (5.4) 24.1 (3.2) < 0.001
Weight at Age 40 years (lbs) 156.1 (32.7) 158.5 (33.3) 165.0 (33.4) 154.9 (29.0) 131.8 (21.4) < 0.001
Medication Use
 Diuretics 13.3% (483) 13.2% (191) 21.4% (196) 8.8% (71) 5.5% (25) < 0.001
 Lipid-Lowering Agents 21.4% (776) 25.5% (371) 19.5% (179) 17.7% (143) 18.2% (83) < 0.001
Total Cholesterol (mg/dl) 192.2 (35.0) 193.6 (34.5) 188.9 (36.0) 194.1 (36.3) 191.1 (31.5) < 0.001
Triglycerides (mg/dl) 131.4 (81.9) 131.4 (77.1) 103.2 (57.4) 152.3 (96.2) 150.5 (94.6) < 0.001
Large Artery Elasticity Index (ml/mmHg × 10) 14.2 (5.5) 14.5 (5.7) 14.3 (5.7) 13.7 (5.1) 13.9 (5.3) < 0.001
Internal Carotid Intimal-Medial Thickness (mm) 1.0 (0.5) 1.0 (0.5) 1.0 (0.6) 1.0 (0.5) 0.8 (0.3) < 0.001
Z Score Maximum Intimal-Medial Thickness −0.2 (0.9) −0.2 (0.9) −0.1 (0.9) −0.2 (0.8) −0.5 (0.7) < 0.001
Hyperopia 36.8% (1355) 34.9% (526) 36.2% (328) 47.4% (389) 24.9% (112) < 0.001
Astigmatism 43.4% (1598) 44.6% (672) 42.1% (381) 38.7% (317) 50.8% (228) < 0.001
Genotypes
ARMS2 RS3793917 < 0.001
  CC 6.6% (234) 3.8% (56) 5.7% (47) 5.6% (45) 19.6% (86)
  CG 36.2% (1285) 34.0% (503) 34.0% (279) 34.5% (278) 51.3% (225)
  GG 57.2% (2027) 62.3% (923) 60.2% (494) 59.9% (482) 29.2% (128)
CFH Y402H RS1061170 < 0.001
  AA 58.3% (950) 39.6% (170) 44.8% (168) 57.9% (235) 89.6% (377)
  AG 33.8% (551) 47.6% (204) 44.5% (167) 33.7% (137) 10.2% (43)
  GG 8.0% (130) 12.8% (55) 10.7% (40) 8.4% (34) 0.2% (1)

-- = cannot be calculated; SD=standard deviation.

*

Measured at baseline examination (collected prior to visit 5 when follow-up eye examination occurred). Characteristics were selected for inclusion in this Table if the characteristic had a p<0.10 in preliminary analyses of incident AMD in which each variable was considered separately, controlling for age, sex, and race/ethnicity. See Supplemental Table 1 for other characteristics considered. CFH Y402H RS1061170 was available only for a subset of participants (n=2451).

**

P-values represent the results of testing for equality among racial/ethnic groups, controlling for age and sex. General linear models were utilized for continuous variables and logistic regression models were utilized for categorical variables.